Clinical Trials on Astrocytomas

Total 1777 results

Beijing Pearl Biotechnology Limited Liability Company

Active, not recruiting

A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).

Glioblastoma

China
Maastricht Radiation Oncology

Active, not recruiting

Patient-derived Glioma Stem Cell Organoids

Glioblastoma

Netherlands
Beijing Sanbo Brain Hospital

Completed

A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse

Glioblastoma
Northwestern University
National Cancer Institute (NCI)

Active, not recruiting

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Glioblastoma

United States
Kiarash Shahlaie, M.D., Ph.D.
National Cancer Institute (NCI)

Completed

Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma

Glioblastoma

United States
Roswell Park Cancer Institute

No longer available

SurVaxM Expanded Access Protocol (EAP)

Glioblastoma
University of Aarhus

Withdrawn

TMS Electrochemotherapy for Glioblastoma Multiforme

Glioblastoma
University Hospital, Basel, Switzerland

Completed

Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas (GBM-LIPO)

Glioblastoma

Switzerland
CytoVac A/S

Completed

Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma (ALECSAT)

Glioblastoma

Sweden
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University

Completed

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Glioblastoma

United States
Tel-Aviv Sourasky Medical Center

Unknown

NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM (NovoTTF-200A)

Glioblastoma

Israel
Boehringer Ingelheim

Completed

Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform

Glioblastoma

United Kingdom
Immatics Biotechnologies GmbH
BioNTech SE; University Hospital Tuebingen; BCN Peptides; EU-funded GAPVAC Consortium

Completed

GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients

Glioblastoma

Spain, Switzerland, Denmark, Germany, Netherlands
Dana-Farber Cancer Institute

Completed

Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma

Glioblastoma

United States
Emory University

Completed

A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma

Glioblastoma

United States
Ohio State University Comprehensive Cancer Center

Withdrawn

Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery

Glioblastoma
Biotech Pharmaceutical Co., Ltd.
Sun Yat-sen University

Completed

Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma

Glioblastoma

China
University Hospital, Basel, Switzerland
University Hospital Inselspital, Berne; Luzerner Kantonsspital; University Hospital...

Terminated

Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner (TOGETHER)

Neoplasms | Glioblastoma

Switzerland
Fondation Ophtalmologique Adolphe de Rothschild

Completed

MRI Detection of Microbleeds in Glioma Patients (SWIGLI)

Glioblastoma
King Faisal Specialist Hospital & Research Center
Radiation Therapy Oncology Group

Completed

Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

Glioblastoma
AHS Cancer Control Alberta

Withdrawn

Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma

Glioblastoma
Shandong Cancer Hospital and Institute

Unknown

A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma

Glioblastoma

China
Merck Sharp & Dohme LLC

Completed

Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)

Glioblastoma
Assistance Publique - Hôpitaux de Paris

Completed

Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma

Glioblastoma

France
Bart Neyns

Terminated

Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma

Glioblastoma

Belgium
Dana-Farber Cancer Institute
Brigham and Women's Hospital; University of Virginia; Schering-Plough

Completed

Prolonged Daily Temozolomide for Low-Grade Glioma

Glioma | Astrocytoma | Oligodendroglioma

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Multiple Sclerosis | Metastatic Malignant Neoplasm in the Brain | Adult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult... and other conditions

United States
Huashan Hospital

Not yet recruiting

Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma

Glioma | Glioblastoma

China
Iacopo Sardi

Recruiting

Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).

Glioblastoma

Italy
Charite University, Berlin, Germany

Recruiting

Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)

Glioblastoma

Germany
Istituto Clinico Humanitas
Mediolanum Cardio Research

Not yet recruiting

Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

Glioblastoma

Italy
Duke University
Glioblastoma Foundation

Recruiting

Glioblastoma Psychosocial Support Program

Glioblastoma

United States
Erasmus Medical Center

Recruiting

Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma (PhysMRRT)

Glioblastoma

Netherlands
University of Aarhus
Danish Cancer Society

Not yet recruiting

Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients

Glioblastoma

Denmark
Henan Provincial People's Hospital

Not yet recruiting

Personalized Trial in ctDNA-level-relapse Glioblastoma

Glioblastoma

China
Henan Provincial People's Hospital

Not yet recruiting

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma

Glioblastoma

China
West Virginia University

Recruiting

Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma (PRIDE)

Glioblastoma

United States
The Affiliated Hospital of Qingdao University

Not yet recruiting

Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma (IBCNG)

Glioblastoma
Weill Medical College of Cornell University

Recruiting

A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging

Glioblastoma

United States
Peking Union Medical College Hospital
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma

Glioblastoma

China
Shanghai Proton and Heavy Ion Center
Fudan University; RenJi Hospital; Ruijin Hospital

Not yet recruiting

Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.

Glioblastoma

China
Medical College of Wisconsin

Recruiting

Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma

Glioblastoma

United States
Centre Oscar Lambret
Erasme University Hospital; Association de Neuro-Oncologues d'Expression Francaise

Recruiting

Treatment Intensification With Temozolomide in Adults With a Glioblastoma (StrateGlio)

Glioblastoma

France
Heinrich-Heine University, Duesseldorf
German Federal Ministry of Education and Research

Recruiting

Efficiency of Vaccination With Lysate-loaded Dendritic Cells in Patients With Newly Diagnosed Glioblastoma (GlioVax)

Glioblastoma

Germany
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma

Glioblastoma

United States
University of Louisville
James Graham Brown Cancer Center

Recruiting

A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70

Glioblastoma

United States
University College, London
Bristol-Myers Squibb

Terminated

A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma (NeAT Glio)

Glioblastoma

United Kingdom
CureVac

Active, not recruiting

Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma

Glioblastoma

Belgium, Germany, Netherlands
Case Comprehensive Cancer Center

Active, not recruiting

Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

Glioma | Glioblastoma

United States
The Cooper Health System
Baylor College of Medicine; Philadelphia College of Osteopathic Medicine

Completed

Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma

Glioblastoma

United States

Clinical Trials on Astrocytomas

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations